Latest Content

  • Plan & Engage Early To Manage the Risks of Risk Management

    Plan & Engage Early To Manage the Risks of Risk Management

    Read More
  • Improving Drug Development & Patient Access With the Right People, Processes, and Culture

    Improving Drug Development & Patient Access With the Right People, Processes, and Culture

    Learn More
  • Learn about Parexel® Biotech

    Learn about Parexel® Biotech

    Read More
  • Three Keys To Mitigating Risk In Adaptive Trials

    Three Keys To Mitigating Risk In Adaptive Trials

    Read More
  • Marketing Authorization In The United States

    Marketing Authorization In The United States

    Read More
  • ×

    Tell Us About Your Biotech Goals.

    What are your top priorities for 2019?
    Thank you!
    Error - something went wrong!
  • Drug development innovations that work: Adaptive trial design - BioPharma Dive

    Drug development innovations that work: Adaptive trial design - BioPharma Dive

    Read More
  • 4 Top Tips for Positioning Your Compound or Company to Investors

    4 Top Tips for Positioning Your Compound or Company to Investors

    Companies seeking an investment should be prepared to provide an objective understanding of their compound’s probability for success: how much it will cost to develop and commercialize, how it will fi

    Learn More
  • regulatory-challenges-for-direct-to-patient-clinical-trials

    regulatory-challenges-for-direct-to-patient-clinical-trials

    Read More
  • Optimizing Clinical Trials To Support Marketing Approval Of Biosimilars

    Optimizing Clinical Trials To Support Marketing Approval Of Biosimilars

    Read More
  • Hidden Value of Patient Centricity in Early Phase Trials

    Hidden Value of Patient Centricity in Early Phase Trials

    Read More
  • Rapid Global Access To Biosimilars Demands Agile, Integrated Development Strategies

    Rapid Global Access To Biosimilars Demands Agile, Integrated Development Strategies

    Read More
  • Key Considerations In US Biosimilars Development

    Key Considerations In US Biosimilars Development

    Read More
  • Leveraging FDA's Accelerated Pathways For Market Advantage

    Leveraging FDA's Accelerated Pathways For Market Advantage

    Successfully leverage the FDA’s accelerated pathways to reach the market more quickly and enhance commercial prospects.

    Read More
  • PAREXEL's Adaptive Trial Design Capabilities

    PAREXEL's Adaptive Trial Design Capabilities

    Read More
  • FOUR TRENDS THAT WILL GUIDE THE FUTURE OF DRUG DEVELOPMENT IN ONCOLOGY

    FOUR TRENDS THAT WILL GUIDE THE FUTURE OF DRUG DEVELOPMENT IN ONCOLOGY

    Read More
  • 4 Ways to Align Real-World Data & Stakeholder Needs

    4 Ways to Align Real-World Data & Stakeholder Needs

    Learn More
  • Driving by Data: A Faster, Better Road to Market

    Driving by Data: A Faster, Better Road to Market

    Prevent Costly Delays.

    Read More
  • Success Starts with the End in Mind

    Success Starts with the End in Mind

    Are you asking the right questions to overcome critical obstacles?

    Learn More
  • How Emerging Companies Can Make Being Small a Strategic Advantage

    How Emerging Companies Can Make Being Small a Strategic Advantage

    Success begins by taking these three big steps toward smarter go/no-go decisions.

    Read More
  • Report: Positioning Emerging BioPharma for Investors

    Report: Positioning Emerging BioPharma for Investors

    Critical insights to help differentiate emerging companies among investors.

    Read More
  • loading
    Loading More...